Here, we show that consistent with previous studies, treatment of DAOY medulloblastoma cells with EGF activated the EGFR signaling cascade and resulted in increased phosphorylation of both the EGFR and the HER2/ErbB2 receptors as well as the downstream targets Erk1/2 and Akt. The gene discussed is MAPK3; the disease is medulloblastoma.